The genetic data suggest the possibility of an association between response to treatment and carriage of either rs4803221 or rs7248668 variants in the IFNL3 (IL-28B) gene locus for the interferon-treated arm in line with association between these two SNPs and previously observed interferon-α2a treatment outcomes in hepatitis C. Here, IFNL3 is linked to hepatitis C virus infection.